• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质纳米颗粒上的抗原间距会影响疫苗接种的抗体反应。

Antigen spacing on protein nanoparticles influences antibody responses to vaccination.

作者信息

Ellis Daniel, Dosey Annie, Boyoglu-Barnum Seyhan, Park Young-Jun, Gillespie Rebecca, Syeda Hubza, Tsybovsky Yaroslav, Murphy Michael, Pettie Deleah, Matheson Nick, Chan Sidney, Ueda George, Fallas Jorge A, Carter Lauren, Graham Barney S, Veesler David, Kanekiyo Masaru, King Neil P

机构信息

Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.

Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.

出版信息

bioRxiv. 2023 May 24:2023.05.23.541980. doi: 10.1101/2023.05.23.541980.

DOI:10.1101/2023.05.23.541980
PMID:37292995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10245855/
Abstract

Immunogen design approaches aim to control the specificity and quality of antibody responses to enable the creation of next-generation vaccines with improved potency and breadth. However, our understanding of the relationship between immunogen structure and immunogenicity is limited. Here we use computational protein design to generate a self-assembling nanoparticle vaccine platform based on the head domain of influenza hemagglutinin (HA) that enables precise control of antigen conformation, flexibility, and spacing on the nanoparticle exterior. Domain-based HA head antigens were presented either as monomers or in a native-like closed trimeric conformation that prevents exposure of trimer interface epitopes. These antigens were connected to the underlying nanoparticle by a rigid linker that was modularly extended to precisely control antigen spacing. We found that nanoparticle immunogens with decreased spacing between closed trimeric head antigens elicited antibodies with improved hemagglutination inhibition (HAI) and neutralization potency as well as binding breadth across diverse HAs within a subtype. Our "trihead" nanoparticle immunogen platform thus enables new insights into anti-HA immunity, establishes antigen spacing as an important parameter in structure-based vaccine design, and embodies several design features that could be used to generate next-generation vaccines against influenza and other viruses.

摘要

免疫原设计方法旨在控制抗体反应的特异性和质量,以创造出具有更高效力和更广谱性的下一代疫苗。然而,我们对免疫原结构与免疫原性之间关系的理解仍然有限。在此,我们利用计算蛋白质设计生成了一种基于流感血凝素(HA)头部结构域的自组装纳米颗粒疫苗平台,该平台能够精确控制纳米颗粒表面抗原的构象、灵活性和间距。基于结构域的HA头部抗原以单体形式或类似天然的封闭三聚体构象呈现,后者可防止三聚体界面表位暴露。这些抗原通过刚性连接子与下层纳米颗粒相连,该连接子可模块化扩展以精确控制抗原间距。我们发现,封闭三聚体头部抗原之间间距减小的纳米颗粒免疫原能诱导出具有更高血凝抑制(HAI)活性和中和效力以及对同一亚型内多种HA结合广度的抗体。因此,我们的“三头”纳米颗粒免疫原平台为抗HA免疫提供了新见解,确立了抗原间距作为基于结构的疫苗设计中的一个重要参数,并体现了几种可用于开发针对流感和其他病毒的下一代疫苗的设计特征。

相似文献

1
Antigen spacing on protein nanoparticles influences antibody responses to vaccination.蛋白质纳米颗粒上的抗原间距会影响疫苗接种的抗体反应。
bioRxiv. 2023 May 24:2023.05.23.541980. doi: 10.1101/2023.05.23.541980.
2
Antigen spacing on protein nanoparticles influences antibody responses to vaccination.蛋白质纳米颗粒上的抗原间距影响疫苗接种后的抗体反应。
Cell Rep. 2023 Dec 26;42(12):113552. doi: 10.1016/j.celrep.2023.113552. Epub 2023 Dec 13.
3
Combinatorial immune refocusing within the influenza hemagglutinin head elicits cross-neutralizing antibody responses.流感血凝素头部内的组合免疫重定向引发交叉中和抗体反应。
bioRxiv. 2023 May 24:2023.05.23.541996. doi: 10.1101/2023.05.23.541996.
4
Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses.流感血凝素 RBD 内的组合免疫重定向可改善交叉中和抗体反应。
Cell Rep. 2023 Dec 26;42(12):113553. doi: 10.1016/j.celrep.2023.113553. Epub 2023 Dec 13.
5
Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.在对历史 H3N2 流感病毒无预存免疫的雪貂中引发针对未来 20 年 H3N2 共循环流感病毒变异株的保护性抗体。
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.00946-18. Print 2019 Feb 1.
6
Comparative Immunogenicity of Bacterially Expressed Soluble Trimers and Nanoparticle Displayed Influenza Hemagglutinin Stem Immunogens.细菌表达的可溶性三聚体和纳米颗粒展示的流感血凝素茎免疫原的免疫原性比较。
Front Immunol. 2022 May 26;13:890622. doi: 10.3389/fimmu.2022.890622. eCollection 2022.
7
Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal influenza vaccines: a comparative, prospective, observational cohort study.基于鸡蛋、基于细胞或基于重组血凝素的季节性流感疫苗引发的血清IgG免疫组库的分子特征:一项比较性、前瞻性、观察性队列研究。
Lancet Microbe. 2025 Feb;6(2):100935. doi: 10.1016/j.lanmic.2024.06.002. Epub 2024 Dec 9.
8
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.新型 H3 特异性广谱中和单克隆抗体的鉴定 该抗体靶向血凝素球状头部,来源于一位具有广泛血清学反应性的流感病毒免疫供者
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01035-19.
9
N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.N-连接聚糖和血凝素 K147 残基协同诱导广泛反应性 H1N1 流感病毒抗体。
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01432-19.
10
Development of a Pan-H1 Influenza Vaccine.开发一种泛 H1 流感疫苗。
J Virol. 2018 Oct 29;92(22). doi: 10.1128/JVI.01349-18. Print 2018 Nov 15.

本文引用的文献

1
Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses.流感血凝素 RBD 内的组合免疫重定向可改善交叉中和抗体反应。
Cell Rep. 2023 Dec 26;42(12):113553. doi: 10.1016/j.celrep.2023.113553. Epub 2023 Dec 13.
2
Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trial.与AS03佐剂联合使用的SARS-CoV-2重组蛋白纳米颗粒疫苗GBP510的免疫原性和安全性:一项随机、活性对照、观察者盲法3期试验的中期结果
EClinicalMedicine. 2023 Sep 7;64:102140. doi: 10.1016/j.eclinm.2023.102140. eCollection 2023 Oct.
3
Top-down design of protein architectures with reinforcement learning.基于强化学习的蛋白质结构的自顶向下设计。
Science. 2023 Apr 21;380(6642):266-273. doi: 10.1126/science.adf6591. Epub 2023 Apr 20.
4
Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine.用于呼吸道合胞病毒疫苗的高免疫原性预融合稳定F糖蛋白抗原的合理设计。
Sci Transl Med. 2023 Apr 26;15(693):eade6422. doi: 10.1126/scitranslmed.ade6422.
5
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.一项多中心、对照的健康成年人感染甲型 H1N1pdm09 流感病毒的人体感染研究。
J Infect Dis. 2023 Aug 11;228(3):287-298. doi: 10.1093/infdis/jiad021.
6
Low protease activity in B cell follicles promotes retention of intact antigens after immunization.B 细胞滤泡中蛋白酶活性低可促进免疫后完整抗原的保留。
Science. 2023 Jan 27;379(6630):eabn8934. doi: 10.1126/science.abn8934.
7
Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors.具有生理 HIV-1 广泛中和抗体前体的人源化 V(D)J 重排和 TdT 表达的小鼠疫苗模型。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2217883120. doi: 10.1073/pnas.2217883120. Epub 2022 Dec 27.
8
Vaccination induces HIV broadly neutralizing antibody precursors in humans.接种疫苗可在人体内诱导产生 HIV 广谱中和抗体前体。
Science. 2022 Dec 2;378(6623):eadd6502. doi: 10.1126/science.add6502.
9
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate.一种经重排的丙型肝炎病毒糖蛋白纳米颗粒疫苗候选物诱导交叉中和抗体。
Nat Commun. 2022 Nov 25;13(1):7271. doi: 10.1038/s41467-022-34961-8.
10
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.拉沙病毒糖蛋白纳米颗粒可引起中和抗体反应和保护作用。
Cell Host Microbe. 2022 Dec 14;30(12):1759-1772.e12. doi: 10.1016/j.chom.2022.10.018. Epub 2022 Nov 17.